Vitrectomy for macular edema due to retinal vein occlusion

References

• Rogers S, McIntosh RL, Cheung N, et al. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology. 2010;117(2):313–9.e1. doi:10.1016/j.ophtha.2009.07.017
   PubMed Web of Science ®Google Scholar
• Tachi N, Hashimoto Y, Ogino N. Vitrectomy for macular edema combined with retinal vein occlusion. Doc Ophthalmol. 1999;97(3–4):465–469.
   Web of Science ®Google Scholar
• Kumagai K, Ogino N, Furukawa M, et al. [Vitreous surgery for macular edema in branch retinal vein occlusion]. Nippon Ganka Gakkai Zasshi. 2002;106(11):701–707.
   Google Scholar
• Furukawa M, Kumagai K, Ogino N, Uemura A, Larson E. Long-term visual outcomes of vitrectomy for cystoid macular edema due to nonischemic central retinal vein occlusion. Eur J Ophthalmol. 2006;16(6):841–846. doi:10.1177/112067210601600609
   Web of Science ®Google Scholar
• Kumagai K, Furukawa M, Ogino N, Larson E, Uemura A. Long-term visual outcomes after vitrectomy for macular edema with foveal hemorrhage in branch retinal vein occlusion. Retina. 2007;27(5):584–588. doi:10.1097/01.iae.0000249576.98520.25
   Web of Science ®Google Scholar
• Kumagai K, Furukawa M, Ogino N, Uemura A, Larson E. Long-term outcomes of vitrectomy with or without arteriovenous sheathotomy in branch retinal vein occlusion. Retina. 2007;27(1):49–54. doi:10.1097/01.iae.0000221996.77421.69
   Web of Science ®Google Scholar
• Kumagai K, Furukawa M, Ogino N, Larson E. Possible effects of internal limiting membrane peeling in vitrectomy for macular vein occlusion. Jpn J Ophthalmol. 2010;54(1):61–65. doi:10.1007/s10384-009-0750-z
   Web of Science ®Google Scholar
• Kumagai K, Ogino N, Furukawa M, Larson E. Three treatments for macular edema because of branch retinal vein occlusion: intravitreous bevacizumab or tissue plasminogen activator, and vitrectomy. Retina. 2012;32(3):520–529. doi:10.1097/IAE.0b013e31822529e2
   Web of Science ®Google Scholar
• Osterloh MD, Charles S. Surgical decompression of branch retinal vein occlusions. Arch Ophthalmol. 1988;106(10):1469–1471.
   Google Scholar
• Opremcak EM, Bruce RA. Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy: a prospective review of 15 cases. Retina. 1999;19(1):1–5.
   PubMed Web of Science ®Google Scholar
• Shah GK, Sharma S, Fineman MS, Federman J, Brown MM, Brown GC. Arteriovenous adventitial sheathotomy for the treatment of macular edema associated with branch retinal vein occlusion. Am J Ophthalmol. 2000;129(1):104–106.
   Web of Science ®Google Scholar
• Opremcak EM, Bruce RA, Lomeo MD, Ridenour CD, Letson AD, Rehmar AJ. Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases. Retina. 2001;21(5):408–415.
   Web of Science ®Google Scholar
• Weiss JN, Bynoe LA. Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology. 2001;108(12):2249–2257.
   Web of Science ®Google Scholar
• Mester U, Dillinger P. Vitrectomy with arteriovenous decompression and internal limiting membrane dissection in branch retinal vein occlusion. Retina. 2002;22(6):740–746.
   Web of Science ®Google Scholar
• Cahill MT, Kaiser PK, Sears JE, Fekrat S. The effect of arteriovenous sheathotomy on cystoid macular oedema secondary to branch retinal vein occlusion. Br J Ophthalmol. 2003;87(11):1329–1332. doi:10.1136/bjo.87.11.1329
   Web of Science ®Google Scholar
• Weizer JS, Stinnett SS, Fekrat S. Radial optic neurotomy as treatment for central retinal vein occlusion. Am J Ophthalmol. 2003;136(5):814–819. doi:10.1016/S0002-9394(03)00698-6
   Web of Science ®Google Scholar
• Garcia-Arumii J, Boixadera A, Martinez-Castillo V, Castillo R, Dou A, Corcostegui B. Chorioretinal anastomosis after radial optic neurotomy for central retinal vein occlusion. Arch Ophthalmol. 2003;121(10):1385–1391. doi:10.1001/archopht.121.10.1385
   Google Scholar
• Williamson TH, Poon W, Whitefield L, Strothidis N, Jaycock P. A pilot study of pars plana vitrectomy, intraocular gas, and radial neurotomy in ischaemic central retinal vein occlusion. Br J Ophthalmol. 2003;87(9):1126–1129. doi:10.1136/bjo.87.9.1126
   Web of Science ®Google Scholar
• Mason J 3rd, Feist R, White M Jr., Swanner J, McGwin G Jr., Emond T. Sheathotomy to decompress branch retinal vein occlusion: a matched control study. Ophthalmology. 2004;111(3):540–545. doi:10.1016/j.ophtha.2003.05.032
   Web of Science ®Google Scholar
• Mandelcorn MS, Nrusimhadevara RK. Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: a report of 14 cases. Retina. 2004;24(3):348–355.
   Web of Science ®Google Scholar
• Yamamoto S, Saito W, Yagi F, Takeuchi S, Sato E, Mizunoya S. Vitrectomy with or without arteriovenous adventitial sheathotomy for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol. 2004;138(6):907–914. doi:10.1016/j.ajo.2004.06.061
   Web of Science ®Google Scholar
• Tsujikawa A, Fujihara M, Iwawaki T, Yamamoto K, Kurimoto Y. Triamcinolone acetonide with vitrectomy for treatment of macular edema associated with branch retinal vein occlusion. Retina. 2005;25(7):861–867.
   Web of Science ®Google Scholar
• Leizaola-Fernandez C, Suarez-Tata L, Quiroz-Mercado H, et al. Vitrectomy with complete posterior hyaloid removal for ischemic central retinal vein occlusion: series of cases. BMC Ophthalmol. 2005;5:10. doi:10.1186/1471-2415-5-10
   PubMedGoogle Scholar
• Ma J, Yao K, Zhang Z, Tang X. 25-gauge vitrectomy and triamcinolone acetonide-assisted internal limiting membrane peeling for chronic cystoid macular edema associated with branch retinal vein occlusion. Retina. 2008;28(7):947–956. doi:10.1097/IAE.0b013e31816c683d
   Web of Science ®Google Scholar
• Chung EJ, Freeman WR, Koh HJ. Visual acuity and multifocal electroretinographic changes after arteriovenous crossing sheathotomy for macular edema associated with branch retinal vein occlusion. Retina. 2008;28(2):220–225. doi:10.1097/IAE.0b013e31813c69df
   Web of Science ®Google Scholar
• Uemura A, Yamamoto S, Sato E, Sugawara T, Mitamura Y, Mizunoya S. Vitrectomy alone versus vitrectomy with simultaneous intravitreal injection of triamcinolone for macular edema associated with branch retinal vein occlusion. Ophthalmic Surg Lasers Imaging. 2009;40(1):6–12. doi:10.3928/15428877-20090101-19
   Google Scholar
• DeCroos FC, Shuler RK Jr., Stinnett S, Fekrat S. Pars plana vitrectomy, internal limiting membrane peeling, and panretinal endophotocoagulation for macular edema secondary to central retinal vein occlusion. Am J Ophthalmol. 2009;147(4):627–633.e1. doi:10.1016/j.ajo.2008.10.024
   Web of Science ®Google Scholar
• Muqit MM, Saidkasimova S, Keating D, Murdoch JR. Long-term study of vascular perfusion effects following arteriovenous sheathotomy for branch retinal vein occlusion. Acta Ophthalmol. 2010;88(3):e57–e65. doi:10.1111/j.1755-3768.2010.01877.x
   Web of Science ®Google Scholar
• Park DH, Kim IT. Long-term effects of vitrectomy and internal limiting membrane peeling for macular edema secondary to central retinal vein occlusion and hemiretinal vein occlusion. Retina. 2010;30(1):117–124. doi:10.1097/IAE.0b013e3181bced68
   Web of Science ®Google Scholar
• Harino S, Bessho K, Kida T. Prospective multicenter study of visual outcomes following three different treatments for macular edema associated with branch retinal vein occlusion: a study by the Japanese BRVO study group. Jpn J Ophthalmol. 2012;56(3):250–261. doi:10.1007/s10384-012-0121-z
   Web of Science ®Google Scholar
• Kadonosono K, Yamane S, Arakawa A, et al. Endovascular cannulation with a microneedle for central retinal vein occlusion. JAMA Ophthalmol. 2013;131(6):783–786. doi:10.1001/jamaophthalmol.2013.2585
   Web of Science ®Google Scholar
• Noma H, Shimada K, Mimura T. Visual function after pars plana vitrectomy in macular edema with branch retinal vein occlusion. Int Ophthalmol. 2013;33(3):227–236. doi:10.1007/s10792-012-9676-4
   Web of Science ®Google Scholar
• Yunoki T, Mitarai K, Yanagisawa S, Kato T, Ishida N, Hayashi A. Effects of vitrectomy on recurrent macular edema due to branch retinal vein occlusion after intravitreal injection of bevacizumab. J Ophthalmol. 2013;2013:415974. doi:10.1155/2013/670242
   Web of Science ®Google Scholar
• Yamane S, Kamei M, Sakimoto S, et al. Matched control study of visual outcomes after arteriovenous sheathotomy for branch retinal vein occlusion. Clin Ophthalmol. 2014;8:471–476. doi:10.2147/OPTH.S58681
   Google Scholar
• Sato S, Inoue M, Yamane S, Arakawa A, Mori M, Kadonosono K. Outcomes of microincision vitrectomy surgery with internal limiting membrane peeling for macular edema secondary to branch retinal vein occlusion. Clin Ophthalmol. 2015;9:439–444. doi:10.2147/OPTH.S75659
   Google Scholar
• Shirakata Y, Fukuda K, Fujita T, et al. Pars plana vitrectomy combined with internal limiting membrane peeling for recurrent macular edema due to branch retinal vein occlusion after antivascular endothelial growth factor treatments. Clin Ophthalmol. 2016;10:277–283. doi:10.2147/OPTH.S85751
   PubMed Web of Science ®Google Scholar
• Nishida A, Kojima H, Kameda T, Mandai M, Kurimoto Y. Five-year outcomes of pars plana vitrectomy for macular edema associated with branch retinal vein occlusion. Clin Ophthalmol. 2017;11:369–375. doi:10.2147/OPTH.S123419
   PubMed Web of Science ®Google Scholar
• Shirakata Y, Fujita T, Nakano Y, Shiraga F, Tsujikawa A. Pars plana vitrectomy combined with internal limiting membrane peeling to treat persistent macular edema after anti-vascular endothelial growth factor treatment in cases of ischemic central retinal vein occlusion. Case Rep Ophthalmol. 2016;7(1):1–8. doi:10.1159/000443322
   Google Scholar
• Tachi N, Hashimoto Y, Ogino N. Cystotomy for diabetic cystoid macular edema. Doc Ophthalmol. 1999;97(3–4):459–463.
   Web of Science ®Google Scholar
• Thompson JT. What is the role of vitrectomy for macular edema from branch retinal vein occlusion? Am J Ophthalmol. 2004;138(6):1037–1038. doi:10.1016/j.ajo.2004.08.063
   Web of Science ®Google Scholar
• McIntosh RL, Mohamed Q, Saw SM, Wong TY. Interventions for branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology. 2007;114(5):835–854. doi:10.1016/j.ophtha.2007.01.010
   Web of Science ®Google Scholar
• Mohamed Q, McIntosh RL, Saw SM, Wong TY. Interventions for central retinal vein occlusion: an evidence-based systematic review. Ophthalmology. 2007;114(3):507–19, 524. doi:10.1016/j.ophtha.2006.11.011
   Web of Science ®Google Scholar
• Li J, Paulus YM, Shuai Y, Fang W, Liu Q, Yuan S. New developments in the classification, pathogenesis, risk factors, natural history, and treatment of branch retinal vein occlusion. J Ophthalmol. 2017;2017:4936924. doi:10.1155/2017/4936924
   PubMed Web of Science ®Google Scholar
• Ehlers JP, Kim SJ, Yeh S, et al. Therapies for macular edema associated with branch retinal vein occlusion: a report by the American academy of ophthalmology. Ophthalmology. 2017;124(9):1412–1423. doi:10.1016/j.ophtha.2017.03.060
   PubMed Web of Science ®Google Scholar
• Jumper JM, Dugel PU, Chen S, Blinder KJ, Walt JG. Anti-VEGF treatment of macular edema associated with retinal vein occlusion: patterns of use and effectiveness in clinical practice (ECHO study report 2). Clin Ophthalmol. 2018;12:621–629. doi:10.2147/OPTH.S163859
   PubMed Web of Science ®Google Scholar
• Schlenker MB, Thiruchelvam D, Redelmeier DA. Intravitreal anti-vascular endothelial growth factor treatment and the risk of thromboembolism. Am J Ophthalmol. 2015;160(3):569–580.e5. doi:10.1016/j.ajo.2015.06.011
   Web of Science ®Google Scholar
• Campochiaro PA, Hafiz G, Mir TA, et al. Scatter photocoagulation does not reduce macular edema or treatment burden in patients with retinal vein occlusion: the RELATE trial. Ophthalmology. 2015;122(7):1426–1437. doi:10.1016/j.ophtha.2015.04.006
   PubMed Web of Science ®Google Scholar
• Parke DW 3rd, Lum F. Return to the operating room after macular surgery: IRIS registry analysis. Ophthalmology. 2018;125(8):1273–1278. doi:10.1016/j.ophtha.2018.01.009
   PubMed Web of Science ®Google Scholar
• Hayreh SS, Zimmerman MB, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol. 1994;117(4):429–441.
   Web of Science ®Google Scholar
• Hayreh SS, Zimmerman MB, Beri M, Podhajsky P. Intraocular pressure abnormalities associated with central and hemicentral retinal vein occlusion. Ophthalmology. 2004;111(1):133–141. doi:10.1016/j.ophtha.2003.03.002
   PubMed Web of Science ®Google Scholar
• Kumagai K, Ogino N, Larson E. Mathematical function describing visual gain curves following vitrectomy for different macular diseases. Jpn J Ophthalmol. 2011;55(2):89–92. doi:10.1007/s10384-010-0922-x
   Web of Science ®Google Scholar
• Hayreh SS, Hayreh MS. Hemi-central retinal vein occulsion. Pathogenesis, clinical features, and natural history. Arch Ophthalmol. 1980;98(9):1600–1609.
   Google Scholar
• Joffe L, Goldberg RE, Magargal LE, Annesley WH. Macular branch vein occlusion. Ophthalmology. 1980;87(2):91–98.
   Web of Science ®Google Scholar
• Hayreh SS, Zimmerman MB. Fundus changes in branch retinal vein occlusion. Retina. 2015;35(5):1016–1027. doi:10.1097/IAE.0000000000000418
   Web of Science ®Google Scholar
• Rogers SL, McIntosh RL, Lim L, et al. Natural history of branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology. 2010;117(6):1094–1101.e5. doi:10.1016/j.ophtha.2010.01.058
   PubMed Web of Science ®Google Scholar
• Quinlan PM, Elman MJ, Bhatt AK, Mardesich P, Enger C. The natural course of central retinal vein occlusion. Am J Ophthalmol. 1990;110(2):118–123.
   PubMed Web of Science ®Google Scholar
• Campochiaro PA, Sophie R, Pearlman J, et al. Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study. Ophthalmology. 2014;121(1):209–219. doi:10.1016/j.ophtha.2013.08.038
   PubMed Web of Science ®Google Scholar
• Heier JS, Campochiaro PA, Yau L, et al. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial. Ophthalmology. 2012;119(4):802–809. doi:10.1016/j.ophtha.2011.12.005
   PubMed Web of Science ®Google Scholar
• Clark WL, Boyer DS, Heier JS, et al. Intravitreal aflibercept for macular edema following branch retinal vein occlusion: 52-week results of the VIBRANT study. Ophthalmology. 2016;123(2):330–336. doi:10.1016/j.ophtha.2015.09.035
   PubMed Web of Science ®Google Scholar
• Casselholm de Salles M, Amren U, Kvanta A, Epstein DL. Injection frequency of aflibercept versus ranibizumab in a treat-and-extend regimen for central retinal vein occlusion: a randomized clinical trial. Retina. 2018;1. doi:10.1097/IAE.0000000000002171
   Web of Science ®Google Scholar
• DeCroos FC, Todorich B, Alshareef R, et al. Neovascular events in eyes with central retinal vein occlusion undergoing serial bevacizumab or ranibizumab intravitreal injections: a retrospective review. J Ophthalmic Vis Res. 2014;9(4):461–468. doi:10.4103/2008-322X.150825
   Google Scholar
• Brown DM, Wykoff CC, Wong TP, Mariani AF, Croft DE, Schuetzle KL. Ranibizumab in preproliferative (ischemic) central retinal vein occlusion: the rubeosis anti-VEGF (RAVE) trial. Retina. 2014;34(9):1728–1735. doi:10.1097/IAE.0000000000000191
   PubMed Web of Science ®Google Scholar
• Winegarner A, Wakabayashi T, Fukushima Y, et al. Changes in retinal microvasculature and visual acuity after antivascular endothelial growth factor therapy in retinal vein occlusion. Invest Ophthalmol Vis Sci. 2018;59(7):2708–2716. doi:10.1167/iovs.17-23437
   PubMed Web of Science ®Google Scholar
• Smiddy WE. Economic considerations of macular edema therapies. Ophthalmology. 2011;118(9):1827–1833. doi:10.1016/j.ophtha.2010.12.034
   PubMed Web of Science ®Google Scholar
• Lin J, Chang JS, Yannuzzi NA, Smiddy WE. Cost evaluation of early vitrectomy versus panretinal photocoagulation and intravitreal ranibizumab for proliferative diabetic retinopathy. Ophthalmology. 2018;125(9):1393–1400. doi:10.1016/j.ophtha.2018.02.038
   Web of Science ®Google Scholar
• Williamson TH, Grewal J, Gupta B, Mokete B, Lim M, Fry CH. Measurement of PO2 during vitrectomy for central retinal vein occlusion, a pilot study. Graefes Arch Clin Exp Ophthalmol. 2009;247(8):1019–1023. doi:10.1007/s00417-009-1072-z
   PubMed Web of Science ®Google Scholar
• Stefansson E. Physiology of vitreous surgery. Graefes Arch Clin Exp Ophthalmol. 2009;247(2):147–163. doi:10.1007/s00417-008-0980-7
   PubMed Web of Science ®Google Scholar
• Nakano Y, Manabe K, Osaka R, et al. The effect of vitreomacular and cataract surgery on oxygen saturation in retinal vessels. Clin Ophthalmol. 2017;11:759–765. doi:10.2147/OPTH.S132392
   Web of Science ®Google Scholar
• Schepens CL, Avila MP, Jalkh AE, Trempe CL. Role of the vitreous in cystoid macular edema. Surv Ophthalmol. 1984;28:Suppl:499–504. doi:10.1016/0039-6257(84)90232-7
   Web of Science ®Google Scholar
• Sebag J, Balazs EA. Pathogenesis of cystoid macular edema: an anatomic consideration of vitreoretinal adhesions. Surv Ophthalmol. 1984;28(Suppl):493–498.
   Web of Science ®Google Scholar
• Nasrallah FP, Jalkh AE, Van Coppenolle F, et al. The role of the vitreous in diabetic macular edema. Ophthalmology. 1988;95(10):1335–1339.
   PubMed Web of Science ®Google Scholar
• Roldan M, Serrano JM. Macular edema and vitreous detachment. Ann Ophthalmol. 1989;21(4):141–148.
   Google Scholar
• Diamond JG, Kaplan HJ. Lensectomy and vitrectomy for complicated cataract secondary to uveitis. Arch Ophthalmol. 1978;96(10):1798–1804.
   PubMedGoogle Scholar
• Stefánsson E, Novack RL, Hatchell DL. Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci. 1990;31(2):284–289.
   PubMed Web of Science ®Google Scholar
• Tachi N, Ogino N. Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol. 1996;122(2):258–260.
   Web of Science ®Google Scholar